Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
29 Julio 2022 - 3:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
July 29, 2022 (July 28, 2022)
COMPUTE HEALTH ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-40001 |
|
85-3449307 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
1105
North Market Street
4th
Floor
Wilmington,
DE 19890
(Address
of principal executive offices) (Zip Code)
(212) 829-3500
(Registrant’s telephone number, including area
code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☒ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant |
|
CPUH.U |
|
The New York Stock Exchange |
|
|
|
|
|
Class A common stock, par value $0.0001 per share |
|
CPUH |
|
The New York Stock Exchange |
|
|
|
|
|
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 |
|
CPUH WS |
|
The New York Stock Exchange |
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ☒
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01 Entry into a Material Definitive Agreement.
On July 28, 2022, Compute Health
Acquisition Corp. (“Compute Health”) entered into a Loan Note Instrument (the “Loan Note”) with
Compute Health Sponsor LLC (“Payee”), pursuant to which, Payee, in its sole and absolute discretion, may loan to Compute
Health up to $1,500,000 for costs reasonably related to Compute Health’s consummation of an initial business combination. The Loan
Note does not bear any interest.
The Loan Note is payable on the
earliest to occur of (i) the date on which Compute Health consummates its initial business combination and (ii) the date that the winding
up of Compute Health is effective.
The Loan Note is subject to customary
events if default, including failure by Compute Health to pay the principal amount due pursuant to the Loan Note within five business
days of the Maturity Date and certain bankruptcy events of Compute Health.
A copy of the Loan Note is
filed as Exhibit 10.1 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference
to the full text of the Loan Note.
Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The disclosure set forth above
in Item 1.01 of this Current Report on Form 8-K are incorporated by reference into this Item 2.03.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
COMPUTE HEALTH ACQUISITION CORP. |
|
|
|
|
By: |
/s/ Joshua Fink |
|
|
Name: |
Joshua Fink |
|
|
Title: |
Co-Chief Executive Officer |
|
|
|
Dated: July 29, 2022 |
|
|
2
Compute Health Acquisition (NYSE:CPUH)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Compute Health Acquisition (NYSE:CPUH)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024